Hypotriglyceridemic effects of brown seaweed consumption via regulation of bile acid excretion and hepatic lipogenesis in high fat diet-induced obese mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: The present study aimed to further investigate the potential health beneficial effects of long-term seaweed supplementation on lipid metabolism and hepatic functions in DIO mice. MATERIALS/METHODS: Four brown seaweeds (Undaria pinnatifida [UP], Laminaria japonica [LJ], Sargassum fulvellum [SF], or Hizikia fusiforme [HF]) were added to a high fat diet (HFD) at a 5% ratio and supplemented to C57BL/6N mice for 16 weeks. Triglycerides (TGs) and total cholesterol (TC) in the liver, feces, and plasma were measured. Fecal bile acid (BA) levels in feces were monitored. Hepatic insulin signaling- and lipogenesis-related proteins were evaluated by Western blot analysis. RESULTS: Fasting blood glucose levels were significantly reduced in the LJ, SF, and HF groups compared to the HFD group by the end of 16-week feeding period. Plasma TG levels and hepatic lipid accumulation were significantly reduced in all 4 seaweed supplemented groups, whereas plasma TC levels were only suppressed in the UP and HF groups compared to the HFD group. Fecal BA levels were significantly elevated by UP, LJ, and SF supplementation compared to HFD feeding only. Lastly, regarding hepatic insulin signaling-related proteins, phosphorylation of 5′-AMP-activated protein kinase was significantly up-regulated by all 4 types of seaweed, whereas phosphorylation of protein kinase B was up-regulated only in the SF and HF groups. Lipogenesis-related proteins in the liver were effectively down-regulated by HF supplementation in DIO mice. CONCLUSIONS: Brown seaweed consumption showed hypotriglyceridemic effects in the prolonged DIO mouse model. Specifically, combinatory regulation of BA excretion and lipogenesis-related proteins in the liver by seaweed supplementation contributed to the reduction of plasma and hepatic TG levels, which inhibited hyperglycemia in DIO mice. Thus, the discrepant and species-specific functions of brown seaweeds provide novel insights for the selection of future targets for therapeutic agents.
Abstract
BACKGROUND/OBJECTIVES: The present study aimed to further investigate the potential health beneficial effects of long-term seaweed supplementation on lipid metabolism and hepatic functions in DIO mice. MATERIALS/METHODS: Four brown seaweeds (Undaria pinnatifida [UP], Laminaria japonica [LJ], Sargassum fulvellum [SF], or Hizikia fusiforme [HF]) were added to a high fat diet (HFD) at a 5% ratio and supplemented to C57BL/6N mice for 16 weeks. Triglycerides (TGs) and total cholesterol (TC) in the liver, feces, and plasma were measured. Fecal bile acid (BA) levels in feces were monitored. Hepatic insulin signaling- and lipogenesis-related proteins were evaluated by Western blot analysis. RESULTS: Fasting blood glucose levels were significantly reduced in the LJ, SF, and HF groups compared to the HFD group by the end of 16-week feeding period. Plasma TG levels and hepatic lipid accumulation were significantly reduced in all 4 seaweed supplemented groups, whereas plasma TC levels were only suppressed in the UP and HF groups compared to the HFD group. Fecal BA levels were significantly elevated by UP, LJ, and SF supplementation compared to HFD feeding only. Lastly, regarding hepatic insulin signaling-related proteins, phosphorylation of 5′-AMP-activated protein kinase was significantly up-regulated by all 4 types of seaweed, whereas phosphorylation of protein kinase B was up-regulated only in the SF and HF groups. Lipogenesis-related proteins in the liver were effectively down-regulated by HF supplementation in DIO mice. CONCLUSIONS: Brown seaweed consumption showed hypotriglyceridemic effects in the prolonged DIO mouse model. Specifically, combinatory regulation of BA excretion and lipogenesis-related proteins in the liver by seaweed supplementation contributed to the reduction of plasma and hepatic TG levels, which inhibited hyperglycemia in DIO mice. Thus, the discrepant and species-specific functions of brown seaweeds provide novel insights for the selection of future targets for therapeutic agents.
참고문헌 (30)
- Lee HS, "A study on the development of high-fiber supplements for the diabetic patients-Effect of seaweed supplementation on the lipid and glucose metabolism in streptozotocin-induced diabetic rats-", Korean J Nutr, 29, pp.296~306 (1996)
- 조영자, "미역첨가 식이가 당뇨 유발쥐의 혈청지질과 혈당 및 항산화 효소에 미치는 영향", 한국식품영양과학회지, 33(6), pp.987~994 (2004), 한국식품영양과학회
- 장민아, "다시마 추출물의 급여가 당뇨쥐의 중성스테로이드와 담즙산 배설에 미치는 영향", 한국식품영양과학회지, 31(5), pp.819~825 (2002), 한국식품영양과학회
- Khan MN, "Anti-inflammatory activities of methanol extracts from various seaweed species", J Environ Biol, 29, pp.465~469 (2008)
- Cumashi A, "A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds", Glycobiology, 17, pp.541~552 (2007)
- 한지숙, "다시마추출물이 제2형 당뇨병 환자의 혈당, 지질 및 항산화 체계에 미치는 영향", 한국식품영양과학회지, 36(11) (2007), 한국식품영양과학회
- Park SH, "The effect of dietary fiber feeding on gastrointestinal functions and lipid and glucose metabolism in streptozotocin-induced diabetic rats", Korean J Nutr, 27, pp.311~322 (1994)
- Jiménez-Escrig A, "Dietary fibre from edible seaweeds : chemical structure, physicochemical properties and effects on cholesterol metabolism", Nutr Res, 20, pp.585~598 (2000)
- 최재석, "시판 미역의 영양성분 및 생리활성 분석", 생명과학회지, 18(3), pp.387~394 (2008), 한국생명과학회
- Narayan B, "Comparative evaluation of fatty acid composition of different Sargassum(Fucales, Phaeophyta)species harvested from temperate and tropical waters", J Aquat Food Prod Technol, 13, pp.53~70 (2005)
- Ji-Hyun Oh, "Anti-inflammatory and anti-diabetic effects of brown seaweeds in high-fat diet-induced obese mice", Nutrition Research and Practice, 10(1), pp.42~48 (2016), 한국영양학회
- Kang SY, "Anti-diabetic effects and anti-inflammatory effects of Laminaria japonica and Hizikia fusiforme in skeletal muscle : in vitro and in vivo model", Nutrients, 10, pp.491~ (2018)
- Jang WS, "Antiobesity effects of the ethanol extract of Laminaria japonica Areshoung in high-fat-diet-induced obese rat", Evid Based Complement Alternat Med, 2013, pp.492807~ (2013)
- Grasa-López A, "Undaria pinnatifida and fucoxanthin ameliorate lipogenesis and markers of both inflammation and cardiovascular dysfunction in an animal model of diet-induced obesity", Mar Drugs, 14, pp.148~ (2016)
- Kumar SA, "Seaweeds as potential therapeutic interventions for the metabolic syndrome", Rev Endocr Metab Disord, 14, pp.299~308 (2013)
- Brunt EM, "Pathology of fatty liver disease", Mod Pathol, 20(Suppl 1), pp.S40~S48 (2007)
- Samuel VT, "The pathogenesis of insulin resistance : integrating signaling pathways and substrate flux", J Clin Invest, 126, pp.12~22 (2016)
- Gupta S, "Bioactive potential and possible health effects of edible brown seaweeds", Trends Food Sci Technol, 22, pp.315~326 (2011)
- MacArtain P, "Nutritional value of edible seaweeds", Nutr Rev, 65, pp.535~543 (2007)
- Maeda H, "Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese", diabetic KK-Ay mice, 2007, pp.55, 7701~7706
- Jia RB, "Comparison of physicochemical properties and antidiabetic effects of polysaccharides extracted from three seaweed species", Int J Biol Macromol, 149, pp.81~92 (2020)
- Bocanegra A, "Differential effects of konbu and nori seaweed dietary supplementation on liver glutathione status in normo-and hypercholesterolaemic growing rats", Br J Nutr, 95, pp.696~702 (2006)
- Zha XQ, "Polysaccharides in Laminaria japonica(LP) : extraction, physicochemical properties and their hypolipidemic activities in diet-induced mouse model of atherosclerosis", Food Chem, 134, pp.244~252 (2012)
- Yang Z, "Fucoidan A2 from the brown seaweed Ascophyllum nodosum lowers lipid by improving reverse cholesterol transport in C57BL", 6J mice fed a high-fat diet, 2019, pp.67, 5782~5791
- Horton JD, "SREBPs : activators of the complete program of cholesterol and fatty acid synthesis in the liver", J Clin Invest, 109, pp.1125~1131 (2002)
- Jakulj L, "Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion", Cell Metab, 24, pp.783~794 (2016)
- van der Velde AE, "Transintestinal cholesterol efflux", Curr Opin Lipidol, 21, pp.167~171 (2010)
- Kern F Jr, "Binding of bile acids by dietary fiber", Am J Clin Nutr, 31, pp.S175~S179 (1978)
- Story JA, "Comparison of the binding of various bile acids and bile salts in vitro by several types of fiber", J Nutr, 106, pp.1292~1294 (1976)
- Wang W, "Binding of bile salts to soluble and insoluble dietary fibers of seaweeds", Fish Sci, 67, pp.1169~1173 (2001)